CME Group Inc. (NASDAQ:CME) Shares Bought by Cohen Capital Management Inc.

Cohen Capital Management Inc. raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 31.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,918 shares of the financial services provider’s stock after purchasing an additional 696 shares during the period. Cohen Capital Management Inc.’s holdings in CME Group were worth $644,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Salomon & Ludwin LLC acquired a new position in shares of CME Group during the first quarter valued at about $28,000. Y.D. More Investments Ltd acquired a new position in CME Group during the 2nd quarter valued at approximately $36,000. McClarren Financial Advisors Inc. raised its holdings in shares of CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC lifted its stake in shares of CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. grew its holdings in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,221 shares of company stock valued at $3,351,895. 0.30% of the stock is owned by insiders.

CME Group Price Performance

CME Group stock opened at $225.00 on Monday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company’s fifty day moving average price is $220.69 and its 200 day moving average price is $209.49. The stock has a market capitalization of $81.02 billion, a P/E ratio of 23.51, a P/E/G ratio of 5.67 and a beta of 0.55. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the prior year, the firm earned $2.25 EPS. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. As a group, equities research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date was Monday, September 9th. CME Group’s payout ratio is 48.37%.

Analyst Ratings Changes

A number of brokerages have commented on CME. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a research report on Tuesday, October 8th. JPMorgan Chase & Co. lifted their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price target on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Piper Sandler lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Finally, TD Cowen began coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus price target of $222.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.